U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H20ClN3O3
Molecular Weight 349.812
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZASETRON

SMILES

CN1C(=O)COC2=C(C=C(Cl)C=C12)C(=O)NC3CN4CCC3CC4

InChI

InChIKey=WUKZPHOXUVCQOR-UHFFFAOYSA-N
InChI=1S/C17H20ClN3O3/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23)

HIDE SMILES / InChI
Molecular Formula C17H20ClN3O3
Molecular Weight 349.812
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:37:08 UTC 2023
Edited
by admin
on Fri Dec 15 16:37:08 UTC 2023
Record UNII
77HC7URR9Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZASETRON
INN   MI   WHO-DD  
INN  
Official Name English
(±)-6-CHLORO-3,4-DIHYDRO-4-METHYL-3-OXO-N-3-QUINUCLIDINYL-2H-1,4-BENZOXAZINE-8-CARBOXAMIDE
Systematic Name English
Azasetron [WHO-DD]
Common Name English
azasetron [INN]
Common Name English
AZASETRON [MI]
Common Name English
ARAZASETRON, (±)-
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C267
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
NCI_THESAURUS C94726
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
Code System Code Type Description
FDA UNII
77HC7URR9Z
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
IUPHAR
2285
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
SMS_ID
100000086078
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
MESH
C070671
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
CAS
123040-69-7
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
EPA CompTox
DTXSID7045651
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
INN
7005
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
NCI_THESAURUS
C73101
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
PUBCHEM
2264
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
DRUG CENTRAL
267
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
EVMPD
SUB05642MIG
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
WIKIPEDIA
AZASETRON
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
MERCK INDEX
m2163
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY Merck Index
ChEMBL
CHEMBL1598608
Created by admin on Fri Dec 15 16:37:08 UTC 2023 , Edited by admin on Fri Dec 15 16:37:08 UTC 2023
PRIMARY
Related Record Type Details
Structure of AZASETRON HYDROCHLORIDE
SALT/SOLVATE -> PARENT
5-HYDROXYTRYPTAMINE RECEPTOR 3B
TARGET -> INHIBITOR
5-HYDROXYTRYPTAMINE RECEPTOR 3
TARGET -> INHIBITOR
Related Record Type Details
Structure of AZASETRON
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966